These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3035388)

  • 21. [Prevention of neonatal alloimmune thrombocytopenia fetal maternal rhesus].
    Poissonnier MH
    J Gynecol Obstet Biol Reprod (Paris); 2007 Sep; 36 Suppl 1():S12-5. PubMed ID: 18228707
    [No Abstract]   [Full Text] [Related]  

  • 22. Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin?
    Hannafin B; Lovecchio F; Blackburn P
    Am J Emerg Med; 2006 Jul; 24(4):487-9. PubMed ID: 16787810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 24. The global burden of Rh disease.
    Zipursky A; Paul VK
    Arch Dis Child Fetal Neonatal Ed; 2011 Mar; 96(2):F84-5. PubMed ID: 21037283
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of D isoimmunization. ACOG Technical Bulletin number 147--October 1990.
    Int J Gynaecol Obstet; 1992 Jan; 37(1):53-6. PubMed ID: 1346604
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antepartum prophylaxis: the final step in the Rh isoimmunization problem?].
    Brandes J; Fisher M
    Harefuah; 1989 Nov; 117(10):340-1. PubMed ID: 2559005
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of Rh immunization. II. Management of the risk during the second half of pregnancy and postpartum].
    Larsen JF; Bock JE; Jørgensen JR
    Ugeskr Laeger; 2004 Aug; 166(36):3078-83. PubMed ID: 15387304
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevention of Rh immunization. I. Theoretical background and management of the risk during the first half of pregnancy].
    Larsen JF; Bock JE; Jørgensen JR
    Ugeskr Laeger; 2004 Aug; 166(36):3073-8. PubMed ID: 15387303
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-D guidelines.
    Kanjilal K; Tasker M
    Br J Fam Plann; 2000 Oct; 26(4):244. PubMed ID: 11053891
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antenatal anti-Rh(D) antigen prophylaxis].
    Katsulov A;
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():3-7. PubMed ID: 11785354
    [No Abstract]   [Full Text] [Related]  

  • 31. Fetal-maternal bleed in the second trimester of pregnancy. A report of two cases.
    Gass ML; Carey PM
    J Reprod Med; 1992 Apr; 37(4):378-80. PubMed ID: 1317453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevention of Rh immunization.
    Bowman JM
    Transfus Med Rev; 1988 Sep; 2(3):129-50. PubMed ID: 2856526
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

  • 34. Rhesus sensitisation.
    Allan A
    Mod Midwife; 1995 Nov; 5(11):24-6. PubMed ID: 7583418
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-D administration in early pregnancy--time for a new protocol.
    Carmody F
    Aust N Z J Obstet Gynaecol; 1996 May; 36(2):227-8. PubMed ID: 8798328
    [No Abstract]   [Full Text] [Related]  

  • 36. Why women are not receiving anti-Rh prophylaxis.
    Tovey LA
    Br Med J (Clin Res Ed); 1987 Feb; 294(6570):508. PubMed ID: 3030482
    [No Abstract]   [Full Text] [Related]  

  • 37. Kleihauer testing. Many cases of sensitisation may be avoidable.
    Murphy WG; Ghosh S; Hughes RH; Craig JI; Greer IA
    BMJ; 1994 Sep; 309(6957):806. PubMed ID: 7848430
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical guidelines on anti-D prophylaxis: hasty critics?].
    Carbonne B; Marpeau L; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):526-8. PubMed ID: 17893030
    [No Abstract]   [Full Text] [Related]  

  • 39. Kleihauer testing. Need not be abandoned.
    Love EM; Shwe KH
    BMJ; 1994 Sep; 309(6957):805. PubMed ID: 7950581
    [No Abstract]   [Full Text] [Related]  

  • 40. Cochrane made simple. Anti-D administration during pregnancy for preventing Rhesus isoimmunisation.
    Anderson T
    Pract Midwife; 1999 Jun; 2(6):10. PubMed ID: 10481667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.